Table 2.

Key findings from the first studies to apply the 2017 AAP CPG

Study(ref no.)	Study design/population	Key findings comparing the AAP CPG to the Fourth Report
Sharma et al. [16•]	Cross-sectional, NHANES	• ↑ in HBP (11.8 to 14.2%) with AAP CPG • ↑ likelihood of greater CVD risk in those upward reclassified
Khoury et al. [17•]	Cross-sectional, population with increased CVD risk	• ↑ in HTN among a high-risk population (8 to 13%) • ↑ adolescent/obese participants upward reclassified • ↑ sensitivity in identification of TOD in HTN patients
Dong et al. [18•]	Cross-sectional, Chinese youth	• ↑ in HBP (10.8 to 16.7% in children, 6.3 to 7.9% adolescents) • Greatest ↑ in males, ages 9–11 years, obese, tall; no change for adolescent females, children of short stature
Al Kibria et al. [20•]	Cross-sectional, NHANES, 2 periods	• Modest ↑ in HBP/HTN, greater for the earlier time period • ↑ proportion of obese, male participants
Bell et al. [21•]	Cohort, Houston school-based screening program	• ↑ in HBP (14.8 to 16.3%) but prevalence of HTN slightly J (2.7 to 2.3%) • Over-representation of ages 11 to 15 years Key findings comparing the AAP CPG to the ESHG
Di Bonito et al. [26•]	Cross-sectional, from CARITALY study	• ↑ of 4.1% in HBP • ↑ proportion of overweight and obese participants • ↑ sensitivity for identification of ALVG with 95th percentile cutoffs but no association with adult cut-off

Abbreviations: HBP, high blood pressure; AAP CPG, 2017 AAP Clinical Practice Guidelines; ALVG, abnormal left ventricular geometry; BMI, body mass index; CVD, cardiovascular disease; Fourth Report, 2004 Fourth Report; HTN, hypertension; NHANES, National Health and Nutrition Examination Survey; TOD, target organ damage